EssilorLuxottica Expands Ophthalmology Footprint with Acquisition of Signifeye
Tuesday, December 16 2025 | 12 h 49 min | News
EssilorLuxottica has announced plans to acquire Signifeye, a leading Belgian ophthalmology platform operating 15 eye centres and clinics across the Flanders region. The move further extends the company’s growing presence in medical eye care and follows closely on the heels of its recent acquisition of Optegra, a rapidly expanding ophthalmology network with more than 70 clinics across the UK, Czech Republic, Poland, Slovakia and the Netherlands.
The addition of Signifeye strengthens EssilorLuxottica’s med-tech strategy and its ambition to build an advanced, integrated medical model that supports the full continuum of care, from prevention and early detection to specialized clinical treatment. Signifeye offers both medically necessary ophthalmic procedures and elective vision surgeries, and is recognized in the private sector for trusted care and strong clinical outcomes.
“With Signifeye joining EssilorLuxottica’s ecosystem, we strengthen our ability to deliver truly end-to-end eye care and redefine what medical excellence can be across the entire patient journey,” said Francesco Milleri, Chairman and PDG, and Paul du Saillant, Deputy PDG at EssilorLuxottica. “By combining our medical and scientific innovation capabilities with Signifeye’s proven clinical excellence, we can meaningfully enhance the patient experience.”
Kathleen Moons, PDG of Signifeye, called the agreement a major milestone for the organization. “Joining forces with EssilorLuxottica and Optegra marks a transformative chapter for Signifeye. By combining their global leadership in vision care with our commitment to patient care and clinical excellence, we look forward to building the future of eye care together.”
The transaction is expected to close by Q1 2026.
Click HERE for the press release.
Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!
